Hep C BC Legacy – Page 125 – Hep C BC Legacy

Hep C BC Legacy

Hep C BC Legacy

Blog Archive

AbbVie Initiates Enrollment of Six Global Phase 3 Clinical Studies for Once-Daily, Pan-Genotypic Hepatitis C Regimen

This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at…

Hep C BC Legacy
January 12, 2016

Blog Archive

Pricey hepatitis C drugs threaten health care system

This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at…

Hep C BC Legacy
January 12, 2016

Blog Archive

Medical Tourism in India: How Does It Work?

This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at…

Hep C BC Legacy
January 11, 2016

Blog Archive

Canadian Govt. Recommends Treatment for All

This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at…

Hep C BC Legacy
January 11, 2016

Blog Archive

Action Hepatitis Canada Age Cohort Testing Position Statement

This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at…

Hep C BC Legacy
January 6, 2016

Blog Archive

Inside the hepatitis C virus is a promising antiviral

This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at…

Hep C BC Legacy
January 5, 2016

Blog Archive

Gilead Announces U.S. FDA Priority Review Designation for Sofosbuvir/Velpatasvir

This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at…

Hep C BC Legacy
January 4, 2016

Blog Archive

The drug that costs more than $1200, and sells for $5 in India

This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at…

Hep C BC Legacy
January 4, 2016